Heart, Lung and Circulation
Volume 18, Issue 3 , Pages 184-190 , June 2009

Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries

  • Bryan P. Yan, MBBS

      Affiliations

    • Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
    • ,
  • David J. Clark, MBBS

      Affiliations

    • Departments of Cardiology, Austin, Australia
    • ,
  • Brian Buxton, MBBS

      Affiliations

    • Department of Cardiothoracic Surgery, Austin, Australia
    • ,
  • Andrew E. Ajani, MBBS, MD

      Affiliations

    • Departments of Cardiology, Royal Melbourne, Australia
    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Monash University, Australia
    • University of Melbourne, Melbourne, Victoria, Australia
    • ,
  • Julian A. Smith, MBBS

      Affiliations

    • Department of Cardiothoracic Surgery, Monash Medical Centre, Australia
    • ,
  • Stephen J. Duffy, MBBS, PhD

      Affiliations

    • Departments of Cardiology, Alfred Hospitals, Australia
    • ,
  • Gil C. Shardey, MBBS

      Affiliations

    • Department of Cardiothoracic Surgery, Monash Medical Centre, Australia
    • ,
  • Peter D. Skillington, MBBS

      Affiliations

    • Department of Cardiothoracic Surgery, Royal Melbourne, Australia
    • ,
  • Omar Farouque, MBBS, PhD

      Affiliations

    • Departments of Cardiology, Austin, Australia
    • ,
  • Michael Yii, MBBS, MS

      Affiliations

    • Department of Cardiothoracic Surgery, St. Vincent Hospitals, Victoria, Australia
    • ,
  • Cheng-Hon Yap, MBBS, MS

      Affiliations

    • Department of Cardiothoracic Surgery, Royal Melbourne, Australia
    • ,
  • Nick Andrianopoulos, MBBS

      Affiliations

    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Monash University, Australia
    • ,
  • Angela Brennan, RN

      Affiliations

    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Monash University, Australia
    • ,
  • Diem Dinh

      Affiliations

    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Monash University, Australia
    • ,
  • Christopher M. Reid, PhD

      Affiliations

    • NHMRC Centre of Clinical Research Excellence in Therapeutics, Monash University, Australia
    • Corresponding Author InformationCorresponding author at: NHMRC Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University Commercial Road, Melbourne, VIC 3004, Australia. Tel.: +61 3 9903 0517.
    • ,
  • on behalf of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS), the Melbourne Interventional Group (MIG)

Received 29 July 2008 ,Accepted 3 October 2008.

References 

  1. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344(8922):563–570
  2. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, et al. ACC/AHA task force on practice guidelines; ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Circulation. 2006;113(1):156–175
  3. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344(15):1117–1124
  4. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360(Sep (9338)):965–970
  5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–1323
  6. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–231
  7. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007;297(18):2001–2009
  8. Reid CM, Rockell M, Skillington PD, Shardey GC, Smith JA, Yii M, et al. Initial twelve months experience and analysis for 2001–2002 from the Australasian Society of Cardiac and Thoracic Surgeons–Victorian database project. Heart Lung Circ. 2004;13(3):291–297
  9. Ajani AE, Szto G, Duffy SJ, Eccleston D, Clark DJ, Lefkovits J, et al. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ. 2006;15(1):44–47
  10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. American College of Cardiology; American Heart Association; Canadian Cardiovascular Society ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. J Am Coll Cardiol. 2004;44(3):671–719
  11. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20
  12. Lee DC, Oz MC, Weinberg AD, Ting W. Appropriate timing of surgical intervention after transmural acute myocardial infarction. J Thorac Cardiovasc Surg. 2003;125(1):115–119
  13. Hannan EL, Michael R, Holmes DR, King SB, Gary W, Ambrose JA, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406–2412
  14. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet. 2004;364(9434):583–591
  15. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356(10):1030–1039
  16. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–2130

PII: S1443-9506(08)00919-0

doi: 10.1016/j.hlc.2008.10.005

Heart, Lung and Circulation
Volume 18, Issue 3 , Pages 184-190 , June 2009

Article Tools

* Image Usage & Resolution